AI prescribing: Nolla Health's acne pilot
- The thread: AI systems writing prescriptions directly for consumers — with the pilot design (human approval for the first cohort, oversight loosening from there), the decay curve on the human check is itself the story.
-
2026-10-05: opened (Verge per Bloomberg, 4:14 PM ET): Nolla Health launched in Utah — scan your face, the AI grades acne severity and "autonomously writes a prescription"; two physicians approve each AI-generated prescription for the first 100 patients, with physician oversight that "gradually loosens." Adjacent to OpenAI's ChatGPT-for-Clinicians vertical (Sep 10) — access first, autonomy next. Watch: expansion beyond Utah/acne, the approval step thinning, any state medical- or prescribing-board response, patient outcomes.
-
2026-10-12→13 (Pichai/Hassabis posts, via the ai-social window): Google's AMIE published in The Lancet (BIDMC Medicine partnership) — the first prospective study of patient-facing conversational diagnostics in a real clinic: clinicians reported the summaries helped prepare for visits in 75% of cases, influenced their approach in more than half, and AMIE's differential diagnoses matched the doctors' final diagnoses 90% of the time. The institutional twin of the Nolla prescribing thread — opposite evidence cultures (prospective peer review vs consumer access). Watch: any product surface, independent clinical read-outs, convergence with the prescribing-oversight arc. https://x.com/demishassabis/status/2109813624453669319